TandemAI

TandemAI has developed an integrated technology platform that combines advanced artificial intelligence and physics-based computation with large-scale in-house wet lab operations. The company’s mission is to lower barriers in early-stage drug discovery by providing turnkey solutions that enable faster identification of high-quality therapeutic candidates. Its offerings are used by biotech companies globally—primarily at the preclinical stage—to accelerate research across multiple modalities. No direct clinical results or proprietary pipeline assets have been disclosed; instead, the company serves as an enabling partner/CRO for others’ pipelines.